Population
In vitro angiotensin-converting enzyme (ACE)
Design
Preclinical
Authors
Loading...
May guide preclinical ACE inhibitor design; leaves open clinical translation in cardiovascular disease.
Describes the biochemical design of carboxyalkanoyl and mercaptoalkanoyl amino acids as potent competitive inhibitors of angiotensin-converting enzyme.
Cushman et al. (1977) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: